Interestingly, while TIMP-1 plasma levels were high, TIMP-2 amounts were low in all cancer subjects and these differences could be due to the characteristic activation mechanism of proMMP-2 and proMMP-9 that includes the participation of TIMP-2 and TIMP-1, respectively [36, 38]. Here, TIMP1 is linked to cancer.